H. Lundbeck, antidepressant project Lu AA21004 moved into clinical phase II

Lundbeck has decided to investigate Lu AA21004 for the treatment of depression in patients and will enrol the first patient in a 400 patient phase II study by the end of third quarter 2006. The decision is based on positive pre-clinical results as well as positive conclusion of the phase I trials in healthy individuals.